Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-11

Clinical Trial Update: Intraoperative Use of I.V. Sodium Fluorescein in Suspected CNS Tumors

View source ↗

Summary

This clinical trial updates the use of intravenous sodium fluorescein during surgery for suspected central nervous system tumors and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium fluorescein (sodium fluorescein)

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: CNS | Status: RECRUITING